Why the study?
Periprocedural antithrombotic management is challenging and carries risks of bleeding and thrombosis, with approaches evolving due to DOACs and shifts away from warfarin bridging.
Provides a practical, stepwise approach to the periprocedural management of antithrombotic agents, reflecting the shift towards DOACs and away from warfarin bridging.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Burnett et al. (2021) conducted a review in Periprocedural management of antithrombotics. Periprocedural management of antithrombotic agents was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: